Woodmont Investment Counsel LLC Has $290,000 Stake in Zoetis Inc. (NYSE:ZTS)

Woodmont Investment Counsel LLC trimmed its position in Zoetis Inc. (NYSE:ZTS) by 4.8% during the third quarter, HoldingsChannel.com reports. The firm owned 1,484 shares of the company’s stock after selling 75 shares during the quarter. Woodmont Investment Counsel LLC’s holdings in Zoetis were worth $290,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Prevail Innovative Wealth Advisors LLC lifted its stake in Zoetis by 24.5% in the 1st quarter. Prevail Innovative Wealth Advisors LLC now owns 18,977 shares of the company’s stock valued at $3,211,000 after acquiring an additional 3,738 shares in the last quarter. M&G Plc bought a new stake in shares of Zoetis in the first quarter worth $19,819,000. Cetera Investment Advisers boosted its holdings in Zoetis by 275.2% during the first quarter. Cetera Investment Advisers now owns 96,085 shares of the company’s stock worth $16,259,000 after purchasing an additional 70,476 shares during the last quarter. Sei Investments Co. grew its position in Zoetis by 19.6% in the first quarter. Sei Investments Co. now owns 370,069 shares of the company’s stock valued at $62,622,000 after purchasing an additional 60,698 shares in the last quarter. Finally, Acadian Asset Management LLC increased its stake in Zoetis by 49.6% in the 1st quarter. Acadian Asset Management LLC now owns 25,051 shares of the company’s stock valued at $4,235,000 after buying an additional 8,302 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on ZTS shares. Piper Sandler increased their price objective on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Argus upgraded Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. JPMorgan Chase & Co. upped their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. BTIG Research increased their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Finally, Stifel Nicolaus boosted their target price on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. Ten analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $221.44.

Zoetis Trading Up 2.3 %

Shares of Zoetis stock opened at $174.34 on Friday. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.09. The business has a fifty day simple moving average of $188.46 and a two-hundred day simple moving average of $179.17. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $201.92. The company has a market capitalization of $78.65 billion, a price-to-earnings ratio of 32.77, a P/E/G ratio of 2.61 and a beta of 0.90.

Zoetis (NYSE:ZTS) last posted its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. During the same quarter last year, the company posted $1.36 EPS. Zoetis’s quarterly revenue was up 11.6% compared to the same quarter last year. Research analysts forecast that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st will be given a $0.432 dividend. This represents a $1.73 annualized dividend and a dividend yield of 0.99%. The ex-dividend date of this dividend is Thursday, October 31st. Zoetis’s payout ratio is 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.